Abstract:BackgroundIt has been observed that Slo1 knockout mice have reduced motor function, and people with certain Slo1 mutations have movement problems, but there is no answer whether the movement disorder is caused by the loss of Slo1 in the nervous system, or skeletal muscle, or both. Here, to ascertain in which tissues Slo1 functions to regulate motor function and offer deeper insight in treating related movement disorder, we generated skeletal muscle-specific Slo1 knockout mice, studied the functional changes in Slo1-deficient skeletal muscle and explored the underlying mechanism. MethodsWe used skeletal muscle-specific Slo1 knockout mice (Myf5-Cre; Slo1(flox/flox) mice, called CKO) as in vivo models to examine the role of Slo1 in muscle growth and muscle regeneration. The forelimb grip strength test was used to assess skeletal muscle function and treadmill exhaustion test was used to test whole-body endurance. Mouse primary myoblasts derived from CKO (myoblast/CKO) mice were used to extend the findings to in vitro effects on myoblast differentiation and fusion. Quantitative real-time PCR, western blot and immunofluorescence approaches were used to analyse Slo1 expression during myoblast differentiation and muscle regeneration. To investigate the involvement of genes in the regulation of muscle dysfunction induced by Slo1 deletion, RNA-seq analysis was performed in primary myoblasts. Immunoprecipitation and mass spectrometry were used to identify the protein interacting with Slo1. A dual-luciferase reporter assay was used to identify whether Slo1 deletion affects NFAT activity. ResultsWe found that the body weight and size of CKO mice were not significantly different from those of Slo1(flox/flox) mice (called WT). Deficiency of Slo1 in muscles leads to reduced endurance (similar to 30% reduction, P < 0.05) and strength (similar to 30% reduction, P < 0.001). Although there was no difference in the general morphology of the muscles, electron microscopy revealed a considerable reduction in the content of mitochondria in the soleus muscle (similar to 40% reduction, P < 0.01). We found that Slo1 was expressed mainly on the cell membrane and showed higher expression in slow-twitch fibres. Slo1 protein expression is progressively reduced during muscle postnatal development and regeneration after injury, and the expression is strongly reduced during myoblast differentiation. Slo1 deletion impaired myoblast differentiation and slow-twitch fibre formation. Mechanistically, RNA-seq analysis showed that Slo1 influences the expression of genes related to myogenic differentiation and slow-twitch fibre formation. Slo1 interacts with FAK to influence myogenic differentiation, and Slo1 deletion diminishes NFAT activity. ConclusionsOur data reveal that Slo1 deficiency impaired skeletal muscle regeneration and slow-twitch fibre formation.

Skeletal muscle-specific Sidt2 knockout in mice induced muscular dystrophy-like phenotype.

Impaired Glucose Tolerance in a Mouse Model of Sidt2 Deficiency.

Sidt2 Regulates Hepatocellular Lipid Metabolism Through Autophagy.

SID1 transmembrane family, member 2 (Sidt2): a novel lysosomal membrane protein.

Lysosomal integral membrane protein Sidt2 plays a vital role in insulin secretion

Slo1 Deficiency Impaired Skeletal Muscle Regeneration and Slow‐twitch Fibre Formation

SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy

Sirtuin 3 Deficiency Accelerates Angiotensin II-induced Skeletal Muscle Atrophy

Skeletal Muscle CSE Deficiency Leads to Insulin Resistance in Mice

Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice

PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells

Sucla2 Knock‐Out in Skeletal Muscle Yields Mouse Model of Mitochondrial Myopathy With Muscle Type–Specific Phenotypes

SMN depletion impairs skeletal muscle formation and maturation in a mouse model of SMA

Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome

The lack of CuZnSOD leads to impaired neurotransmitter release, neuromuscular junction destabilization and reduced muscle strength in mice

Muscle Dysfunction Caused by Loss of Magel2 in a Mouse Model of Prader-Willi and Schaaf-Yang Syndromes.

Muscle-fiber specific genetic manipulation of Drosophila sallimus severely impacts neuromuscular development, morphology, and physiology

Pathological features of glycogen storage disease type II highlighted in the knockout mouse model

Skeletal Muscle‐specific DJ‐1 Ablation‐induced Atrogenes Expression and Mitochondrial Dysfunction Contributing to Muscular Atrophy

Indices of Defective Autophagy in Whole Muscle and Lysosome Enriched Fractions From Aged D2-mdx Mice

Lmod2piggyBac Mutant Mice Exhibit Dilated Cardiomyopathy